常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-19.00/-0.86
|
|
企业价值
51.23M
|
| 资产负债 |
|
每股账面净值
-0.87
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
0.58
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| NovaBay Pharmaceuticals Inc is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The company's initial digital asset focus is the Sky protocol ecosystem, with SKY as its core holding. Through staking and other on-chain activities, it seeks to generate protocol-level economic returns while maintaining rigorous governance and risk management oversight. |

1.81 
